glp-1 gastrointestinal obstruction lawsuit in west virginia gastroparesis semaglutide gastric stasis law firm attorney west virginia Gastroparesis Ozempic Lawsuits GLP-1 medications like semaglutide and

The identical pharmacology underneath Platform breadth aside, both deliver the same compound class

The NCE period for tirzepatide runs through May 13, 2027, which means generic companies may not file an ANDA seeking approval for a generic version of Mounjaro or Zepbound until May 13, 2026, with patent infringement lawsuits expected to occur in the following months

One interesting role of glutathione is that it helps recycle other antioxidants

We know these drugs can lead to weight loss, but if youre losing a lot of muscle, this might be bad for the elderly. Weight regain after stopping is a concern, as are GI side effects and intense rebound hunger cravings

Others: Roche, J&J, Sanofi, and AZ have had GLP-1 efforts (some deprioritized) or new dual/triple agonists in development (e.g., Roches pipeline includes a dual agonist announced in 2024)

[DOI] [PubMed] [Google Scholar] 24.Prusinski Fernung L.E., Al-Hendy A., Yang Q